Carisma Therapeutics, Inc.CARMNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank79
3Y CAGR+20.4%
5Y CAGR+26.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+20.4%/yr
vs -5.2%/yr prior
5Y CAGR
+26.4%/yr
Recent deceleration
Acceleration
+25.6pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
3.2x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $16.38M | -18.7% |
| 2024 | $20.14M | -31.8% |
| 2023 | $29.52M | +214.8% |
| 2022 | $9.38M | -68.1% |
| 2021 | $29.39M | +477.9% |
| 2020 | $5.09M | -58.3% |
| 2019 | $12.21M | +5.0% |
| 2018 | $11.62M | +47.1% |
| 2017 | $7.90M | -30.9% |
| 2016 | $11.44M | - |